Dario A. Paggiarino, Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 45,826 shares at $21.13 ($968K) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($968k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.13 | 22,913 | $484K | 50.0% |
| 2 | $21.13 | 22,913 | $484K | 50.0% |
| Total | $21.13 avg | 45,826 | $968K | 100% |
| Filing → |
| EYPT | SELL | 2024-01-25 | $551K | — | Filing → |
| EYPT | SELL | 2023-12-15 | $29K | — | Filing → |
| EYPT | SELL | 2023-12-06 | $674K | — | Filing → |